Prins R - Search Results

1

Implementing liquid biopsies into clinical decision making for cancer immunotherapy.

Quandt D, Dieter Zucht H, Amann A, Wulf-Goldenberg A, Borrebaeck C, Cannarile M, Lambrechts D, Oberacher H, Garrett J, Nayak T, Kazinski M, Massie C, Schwarzenbach H, Maio M, Prins R, Wendik B, Hockett R, Enderle D, Noerholm M, Hendriks H, Zwierzina H, Seliger B. Quandt D, et al. Among authors: prins r. Oncotarget. 2017 Jul 18;8(29):48507-48520. doi: 10.18632/oncotarget.17397. Oncotarget. 2017. PMID: 28501851 Free PMC article. Review.

2

Immunology and immunotherapy in neurosurgical disease.

Prins RM, Liau LM. Prins RM, et al. Neurosurgery. 2003 Jul;53(1):144-52; discussion 152-3. doi: 10.1227/01.neu.0000068865.34216.3a. Neurosurgery. 2003. PMID: 12823883 Review.

3

Cellular immunity and immunotherapy of brain tumors.

Prins RM, Liau LM. Prins RM, et al. Front Biosci. 2004 Sep 1;9:3124-36. doi: 10.2741/1465. Front Biosci. 2004. PMID: 15353342 Review.

4

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation.

Maio M, Lahn M, Di Giacomo AM, Covre A, Calabrò L, Ibrahim R, Fox B; Siena Think Tank. Maio M, et al. J Exp Clin Cancer Res. 2021 Jul 23;40(1):240. doi: 10.1186/s13046-021-02023-4. J Exp Clin Cancer Res. 2021. PMID: 34301276 Free PMC article.

5

The future of cancer immunotherapy for brain tumors: a collaborative workshop.

Brown CE, Bucktrout S, Butterfield LH, Futer O, Galanis E, Hormigo A, Lim M, Okada H, Prins R, Marr SS, Tanner K. Brown CE, et al. Among authors: prins r. J Transl Med. 2022 May 23;20(1):236. doi: 10.1186/s12967-022-03438-z. J Transl Med. 2022. PMID: 35606815 Free PMC article.

6

Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies.

Khan-Farooqi HR, Prins RM, Liau LM. Khan-Farooqi HR, et al. Among authors: prins rm. Neurol Res. 2005 Oct;27(7):692-702. doi: 10.1179/016164105X49490. Neurol Res. 2005. PMID: 16197806 Review.

7

Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications.

Yang MY, Zetler PM, Prins RM, Khan-Farooqi H, Liau LM. Yang MY, et al. Expert Rev Neurother. 2006 Oct;6(10):1481-94. doi: 10.1586/14737175.6.10.1481. Expert Rev Neurother. 2006. PMID: 17078788 Review.

8

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients.

Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Prins RM, et al. J Immunother. 2013 Feb;36(2):152-7. doi: 10.1097/CJI.0b013e3182811ae4. J Immunother. 2013. PMID: 23377664 Free PMC article. Clinical Trial.

9

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.

Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Everson RG, et al. Among authors: prins rm. Neuro Oncol. 2016 Mar;18(3):368-78. doi: 10.1093/neuonc/nov153. Epub 2015 Sep 1. Neuro Oncol. 2016. PMID: 26330563 Free PMC article.

10

TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination.

Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins HS, Yong WH, Davidson TB, Li G, Liau LM, Prins RM. Hsu M, et al. Among authors: prins rm. Cancer Immunol Res. 2016 May;4(5):412-418. doi: 10.1158/2326-6066.CIR-15-0240. Epub 2016 Mar 11. Cancer Immunol Res. 2016. PMID: 26968205 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page